Potential Cause of Worse Outcomes Among Black Breast Cancer Patients Found

Medscape - December 12, 2022

Maja Oktay, M.D., Ph.D., comments on her study, presented at the San Antonio Breast Cancer Symposium, which suggests that Black women with a particular type of breast cancer have higher levels of a metastasis marker in their tumors after neoadjuvant chemotherapy, compared with white women. Dr. Oktay is co-leader of the Tuor Microenvironment and Metastasis Program at the NCI-designated Montefiore Einstein Cancer Center, professor of pathology at EInstein, and a pathologist at Montefiore.

Additional coverage includes The ASCO Post

Tumor Cells on Brink of Death May Trigger Metastasis

The Scientist - March 25, 2022

Maja Oktay, M.D., Ph.D., talks about cancer metastasis and the tumor microenvironment, which she and colleagues have extensively studied, and how chemotherapy may promote the spread of cancer. Dr. Oktay is professor of pathology and director of the New York Pathology Oncology Group.

Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer

New England Journal of Medicine - December 21, 2017

An editorial highlights research by Drs. Maja Oktay, George Karagiannis, and John Condeelis on the mechanism by which some breast cancer tumor cells resist chemotherapy and go on to metastasize. Dr. Oktay is professor of pathology; Dr. Condeelis is the Judith & Burton P. Resnick Chair in Translational Research and professor and co-chair of anatomy and structural biology; Dr. Karagiannis is a postdoctoral fellow

Study Uncovers Previously Unrecognized Effect of Chemotherapy

NIH - August 15, 2017

NCI’s Cancer Currents blog interviews Dr. Maja Oktay about her recent research that found a previously unrecognized effect of chemotherapy.